Benralizumab for -Negative Hypereosinophilic Syndrome.

Authors
Category Primary study
JournalNew England Journal of Medicine
Year 2019
This article has no abstract
Epistemonikos ID: 890815fd87c76002908d825cd58990bd45b93f4d
First added on: Apr 06, 2025